Peter Altman - 08 Dec 2025 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Reporting relationship: President and CEO, Director
Issuer ticker: BCDA
Reported as of: 08 Dec 2025
Net transaction value: +$223,409
SEC form: 4
Accepted by SEC: 10 Dec 2025, 21:54:52 UTC
Prior SEC filing: 23 Sep 2025
Next SEC filing: 17 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ David McClung, by power of attorney

Key filing fact

Peter Altman filed Form 4 for BioCardia, Inc. (BCDA) on 10 Dec 2025.

Key facts

This page summarizes Peter Altman's Form 4 filing for BioCardia, Inc. (BCDA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Dec 2025, 21:54.

Change

Previous filing in this sequence was filed on 23 Sep 2025.
Current net transaction value: +$223,409.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001647542 Primary reporting owner

Altman Peter

Relationship: President and CEO, Director
Address: C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE
Signature: /s/ David McClung, by power of attorney
Signature date: 10 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCDA transaction

Common Stock

Award

Transaction value: $146,026
Shares: +106,588
Change %: +49%
Price: $1.37
Shares after: 323,350
Date: 08 Dec 2025
Ownership: Direct
Footnotes: F1

BCDA transaction

Common Stock

Tax liability

Transaction value: $77,383
Shares: +56,484
Change %: +27%
Price: $1.37
Shares after: 266,866
Date: 08 Dec 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCDA transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +38,000
Change %: +73%
Price: $0.000000
Shares after: 90,215
Date: 08 Dec 2025
Ownership: Direct
Underlying class: Common stock
Underlying amount: 20,000
Exercise price: $1.37
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on December 8, 2025.

Footnote F2

The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on December 8, 2025 and does not represent a sale by the Reporting Person.

Footnote F3

The option vests and becomes exercisable as to 1/48th of the shares on January 8, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.